Compare Stocks

→ How to camouflage a factory of 53,000 workers (From Stansberry Research) (Ad)

Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS).

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
KHRN Khiron Life Sciences	C$0.04	C$0.04	C$0.04 ▼ C$0.21	C$9.30M	2.64	256,268 shs	24,000 shs
LTY Liberty Biopharma	C$2.00 +∞	C$2.00	C$0.06 ▼ C$2.74	C$21.54M	N/A	23,286 shs	700 shs
NDVA Indiva	C$0.07 +16.7%	C$0.08	C$0.02 ▼ C$0.13	C$13.67M	1.11	98,881 shs	66,695 shs
NXG NXG NextGen Infrastructure Income Fund	$39.23 -0.5%	$37.83	$30.32 ▼ $42.29	N/A	N/A	25,819 shs	21,988 shs

12 Stocks Corporate Insiders are Abandoning

If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?

Get This Free Report

Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
KHRN Khiron Life Sciences	0.00%	0.00%	0.00%	0.00%	-6.98%
LTY Liberty Biopharma	0.00%	0.00%	0.00%	0.00%	0.00%
NDVA Indiva	0.00%	+16.67%	-17.65%	-30.00%	+7.69%
NXG NXG NextGen Infrastructure Income Fund	-0.46%	+5.32%	+3.37%	+17.14%	+18.07%

How to camouflage a factory of 53,000 workers (Ad)

"If I Had To Pour Every Single Penny of My Retirement Into Just ONE STOCK..." The former Goldman Sachs VP – who called everything from Microsoft's 1,100% surge... to the death of the 60/40 portfolio – is now stepping forward with his most explicit message yet: "Make this ONE STOCK the cornerstone of your portfolio."

Get the full story here.

MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
KHRN Khiron Life Sciences	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
LTY Liberty Biopharma	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
NDVA Indiva	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
NXG NXG NextGen Infrastructure Income Fund	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Analyst Ratings

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
KHRN Khiron Life Sciences	N/A	N/A	N/A	N/A
LTY Liberty Biopharma	N/A	N/A	N/A	N/A
NDVA Indiva	3.00	Buy	C$0.15	114.29% Upside
NXG NXG NextGen Infrastructure Income Fund	N/A	N/A	N/A	N/A

Current Analyst Ratings

Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
KHRN Khiron Life Sciences	C$16.14M	0.58	C$0.01 per share	6.67	C$0.12 per share	0.33
LTY Liberty Biopharma	N/A	N/A	C$0.00 per share	2,000.00	C$0.79 per share	N/A
NDVA Indiva	C$36.01M	0.38	C$0.01 per share	5.20	N/A	∞
NXG NXG NextGen Infrastructure Income Fund	$-28.13M	N/A	N/A	N/A	N/A	N/A

Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
KHRN Khiron Life Sciences	-C$30.66M	-C$0.17	N/A	∞	N/A	-190.00%	-74.68%	-20.79%	N/A
LTY Liberty Biopharma	N/A	-C$0.16	N/A	∞	N/A	N/A	N/A	N/A	N/A
NDVA Indiva	-C$6.94M	-C$0.05	N/A	∞	N/A	-19.27%	-288.64%	-6.91%	5/14/2024 (Estimated)
NXG NXG NextGen Infrastructure Income Fund	N/A	-$0.24	N/A	∞	N/A	N/A	N/A	N/A	N/A

Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
KHRN Khiron Life Sciences	N/A	N/A	N/A	N/A	N/A
LTY Liberty Biopharma	N/A	N/A	N/A	N/A	N/A
NDVA Indiva	N/A	N/A	N/A	N/A	N/A
NXG NXG NextGen Infrastructure Income Fund	$5.67	14.45%	+0.29%	N/A	1 Years

Latest NXG, KHRN, LTY, and NDVA Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
2/6/2024	NXG NXG NextGen Infrastructure Income Fund	monthly	$0.54	18.5%	5/14/2024	5/15/2024	5/31/2024
2/1/2024	NXG NXG NextGen Infrastructure Income Fund	monthly	$0.54	18.5%	5/14/2024	5/15/2024	5/31/2024
2/1/2024	NXG NXG NextGen Infrastructure Income Fund	monthly	$0.54	18.5%	4/12/2024	4/15/2024	4/30/2024
2/1/2024	NXG NXG NextGen Infrastructure Income Fund	Monthly	$0.54	18.71%	2/14/2024	2/15/2024	2/29/2024

(Data available from 1/1/2013 forward)

Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
KHRN Khiron Life Sciences	9.46	2.02	0.72
LTY Liberty Biopharma	8.19	0.12	0.12
NDVA Indiva	5,899.22	0.85	0.52
NXG NXG NextGen Infrastructure Income Fund	N/A	N/A	N/A

Ownership

Institutional Ownership

Company	Institutional Ownership
KHRN Khiron Life Sciences	0.22%
LTY Liberty Biopharma	N/A
NDVA Indiva	0.33%
NXG NXG NextGen Infrastructure Income Fund	N/A

Insider Ownership

Company	Insider Ownership
KHRN Khiron Life Sciences	4.64%
LTY Liberty Biopharma	N/A
NDVA Indiva	36.29%
NXG NXG NextGen Infrastructure Income Fund	N/A

Miscellaneous

Company	Employees	Shares Outstanding	Free Float	Optionable
KHRN Khiron Life Sciences	N/A	232.41 million	N/A	Not Optionable
LTY Liberty Biopharma	N/A	10.77 million	N/A	Not Optionable
NDVA Indiva	147,000	195.30 million	N/A	Not Optionable
NXG NXG NextGen Infrastructure Income Fund	N/A	N/A	N/A	N/A

NXG, KHRN, LTY, and NDVA Headlines

Source	Headline
	Japan's GPIF and APG partner up for infrastructure investments pionline.com - April 8 at 10:19 AM
	NBXG: Deep Discount Remains On This Tech-Heavy Fund seekingalpha.com - March 30 at 9:17 AM
	Gas tax hike — which would fund transit infrastructure — moves forward in NJ Senate msn.com - March 12 at 3:56 PM
	Is NHMAX a Strong Bond Fund Right Now? msn.com - February 26 at 10:01 AM
	NXG NextGen Infrastructure Income Fund money.usnews.com - February 21 at 6:46 PM
	VT Gravis UK Infrastructure Income hl.co.uk - February 3 at 2:42 PM
	Chris Eubanks is replacing an injured Taylor Fritz for the US Davis Cup team against Ukraine msn.com - February 1 at 1:06 PM
	Sequoia Economic Infrastructure Income Fund Ltd (SEQI) NPV hl.co.uk - January 30 at 7:10 PM
	NXG Cushing® Midstream Energy Fund (NYSE: SRV) Announces the Preliminary Results of its Rights Offering finance.yahoo.com - December 15 at 9:36 AM
	Blackfinch Group proposes two new funds msn.com - November 17 at 6:10 PM
	Blackfinch Group launches two infrastructure and property funds portfolio-adviser.com - November 16 at 2:55 PM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Company Descriptions

Khiron Life Sciences

CVE:KHRN

Khiron Life Sciences Corp. operates as an integrated medical and cannabis company in Latin America and Europe. It operates through Health Services, Medical Cannabis Products, and Wellbeing Products segments. The company focuses on the cultivation, production, distribution, and export of tetrahydrocannabinol and cannabidiol (CBD) medical cannabis. It also operates a network of health centers and satellite clinics under the ILANS and Zerenia brands; develops CBD-based cosmeceutical products under the Kuida brand name; and operates Zerenia clinic in Medellin and Peru. Khiron Life Sciences Corp. was incorporated in 2012 and is headquartered in Vancouver, Canada.

Liberty Biopharma

CVE:LTY

Liberty Biopharma Inc., a clinical stage biopharmaceutical company, engages in the research, development, and commercialization of an automated bioprocessing and cell isolation technology. Its technology is used in the isolation of regenerative cells from human adipose tissues for use in research, cosmetic and aesthetic medicine, burn management, wound management and non-healing wounds, cardiovascular and heart diseases, peripheral arterial disease, critical limb ischemia or diabetic leg, and hepatic disease and kidney disease. The company was formerly known as Avagenesis Corp. and changed its name to Liberty Biopharma Inc. in January 2017. Liberty Biopharma Inc. is based in Richmond, Canada.

Indiva

CVE:NDVA

Indiva Limited engages in the production, processing, and sale of cannabis and cannabis related products in Canada. It offers pre-rolls, flower, capsules, and edible and extract products under the INDIVA, Indiva Life, and Artisan Batch brands. The company produces and distributes the Bhang Chocolate, Wana Sour Gummies, Jewels Chewable Tarts, Grön edibles, and Dime Industries vape products through license agreements and partnerships. Indiva Limited is based in Ottawa, Canada.

NXG NextGen Infrastructure Income Fund

NYSE:NXG

NXG NextGen Infrastructure Income Fund is a closed ended equity mutual fund launched and managed by Cushing MLP Asset Management, LP. The fund invests in stocks of companies across the energy supply chain spectrum, including upstream, midstream and downstream energy companies, as well as oil and gas services and logistics companies, energy-intensive chemical, metal and industrial and manufacturing companies and engineering and construction companies. NXG NextGen Infrastructure Income Fund was formed in 2012 and is domiciled in the United States.

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial